Qube Research & Technologies LTD United Therapeutics Corp Transaction History

Qube Research & Technologies LTD

$65.7 Billion
Q3 2024

A detailed history of Qube Research & Technologies LTD transactions in United Therapeutics Corp stock. As of the latest transaction made, Qube Research & Technologies LTD holds 53,813 shares of UTHR stock, worth $19.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

53,813

Previous 31,695 69.78%

Holding current value

$19.5 Million

Previous $10.1 Million 91.0%

% of portfolio

0.03%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$311.04 - $363.55 $6.88 Million - $8.04 Million	22,118 Added 69.78%	53,813 $19.3 Million
Q2 2024 Aug 14, 2024	SELL	$228.26 - $319.04 $34.9 Million - $48.8 Million	-152,962 Reduced 82.84%	31,695 $10.1 Million
Q1 2024 May 14, 2024	SELL	$210.76 - $249.51 $4.34 Million - $5.14 Million	-20,587 Reduced 10.03%	184,657 $42.4 Million
Q4 2023 Feb 13, 2024	BUY	$214.88 - $256.94 $26.1 Million - $31.2 Million	121,279 Added 144.44%	205,244 $45.1 Million
Q3 2023 Nov 13, 2023	BUY	$211.82 - $248.24 $899,175 - $1.05 Million	4,245 Added 5.32%	83,965 $19 Million
Q2 2023 Aug 14, 2023	SELL	$205.19 - $232.99 $19.8 Million - $22.5 Million	-96,447 Reduced 54.75%	79,720 $17.6 Million
Q1 2023 May 15, 2023	BUY	$212.99 - $276.17 $6.65 Million - $8.62 Million	31,211 Added 21.53%	176,167 $39.5 Million
Q4 2022 Feb 14, 2023	BUY	$205.95 - $280.43 $16.1 Million - $21.9 Million	77,946 Added 116.32%	144,956 $40.3 Million
Q3 2022 Nov 14, 2022	BUY	$203.3 - $244.17 $13.6 Million - $16.4 Million	67,010 New	67,010 $14 Million
Q2 2022 Aug 15, 2022	SELL	$174.81 - $241.14 $2.72 Million - $3.75 Million	-15,557 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$166.16 - $213.96 $2.58 Million - $3.33 Million	15,557 New	15,557 $2.79 Million
Q4 2021 Feb 01, 2022	SELL	$184.32 - $216.08 $12.2 Million - $14.3 Million	-66,113 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$179.86 - $214.88 $9.34 Million - $11.2 Million	51,904 Added 365.29%	66,113 $12.2 Million
Q2 2021 Aug 13, 2021	BUY	$170.47 - $211.93 $1.11 Million - $1.38 Million	6,505 Added 84.44%	14,209 $2.55 Million
Q1 2021 May 14, 2021	BUY	$153.94 - $174.85 $1.19 Million - $1.35 Million	7,704 New	7,704 $1.29 Million
Q4 2020 Feb 16, 2021	SELL	$101.87 - $151.79 $4.92 Million - $7.33 Million	-48,259 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$99.9 - $121.13 $499,000 - $605,044	4,995 Added 11.55%	48,259 $4.87 Million
Q2 2020 Aug 14, 2020	BUY	$92.74 - $125.82 $4.01 Million - $5.44 Million	43,264 New	43,264 $5.24 Million
Q4 2018 Feb 14, 2019	SELL	$101.4 - $128.73 $146,016 - $185,371	-1,440 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$113.81 - $129.46 $114,720 - $130,495	1,008 Added 233.33%	1,440 $184,000
Q2 2018 Aug 14, 2018	BUY	$101.14 - $118.31 $43,692 - $51,109	432 New	432 $49,000

Others Institutions Holding UTHR

# of Institutions

667

Shares Held

42.7M

Call Options Held

194K

Put Options Held

295K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.5B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD United Therapeutics Corp Transaction History